Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

SELL
$95.27 - $108.47 $14,576 - $16,595
-153 Reduced 3.77%
3,902 $377,000
Q4 2023

Jan 16, 2024

SELL
$92.27 - $101.54 $52,778 - $58,080
-572 Reduced 12.36%
4,055 $409,000
Q3 2023

Nov 03, 2023

BUY
$94.73 - $105.13 $8,525 - $9,461
90 Added 1.98%
4,627 $471,000
Q2 2023

Jul 18, 2023

SELL
$92.52 - $104.91 $353,981 - $401,385
-3,826 Reduced 45.75%
4,537 $457,000
Q1 2023

Apr 18, 2023

BUY
$80.03 - $92.81 $15,365 - $17,819
192 Added 2.35%
8,363 $769,000
Q4 2022

Jan 27, 2023

SELL
$75.55 - $92.52 $32,864 - $40,246
-435 Reduced 5.05%
8,171 $0
Q3 2022

Oct 26, 2022

BUY
$74.61 - $87.26 $4,625 - $5,410
62 Added 0.73%
8,606 $654,000
Q2 2022

Jul 21, 2022

SELL
$80.52 - $93.75 $8,374 - $9,750
-104 Reduced 1.2%
8,544 $722,000
Q1 2022

May 06, 2022

BUY
$80.11 - $90.62 $6,569 - $7,430
82 Added 0.96%
8,648 $758,000
Q4 2021

Feb 01, 2022

SELL
$79.7 - $88.13 $8,209 - $9,077
-103 Reduced 1.19%
8,566 $749,000
Q3 2021

Oct 22, 2021

SELL
$81.78 - $95.14 $120,461 - $140,141
-1,473 Reduced 14.52%
8,669 $708,000
Q2 2021

Jul 28, 2021

BUY
$85.24 - $94.15 $47,137 - $52,064
553 Added 5.77%
10,142 $925,000
Q1 2021

May 04, 2021

SELL
$83.5 - $98.47 $303,773 - $358,233
-3,638 Reduced 27.5%
9,589 $819,000
Q4 2020

Feb 09, 2021

SELL
$78.07 - $94.43 $12,256 - $14,825
-157 Reduced 1.17%
13,227 $1.25 Million
Q3 2020

Oct 22, 2020

BUY
$82.14 - $91.0 $5,339 - $5,915
65 Added 0.49%
13,384 $1.16 Million
Q2 2020

Aug 06, 2020

SELL
$80.93 - $91.1 $24,279 - $27,330
-300 Reduced 2.2%
13,319 $1.16 Million
Q1 2020

Apr 29, 2020

SELL
$70.67 - $99.01 $3,533 - $4,950
-50 Reduced 0.37%
13,619 $1.12 Million
Q4 2019

Jan 14, 2020

SELL
$84.35 - $95.37 $5,482 - $6,199
-65 Reduced 0.47%
13,669 $1.29 Million
Q3 2019

Oct 29, 2019

SELL
$85.54 - $94.26 $60,305 - $66,453
-705 Reduced 4.88%
13,734 $1.19 Million
Q2 2019

Jul 19, 2019

SELL
$75.4 - $92.8 $21,866 - $26,912
-290 Reduced 1.97%
14,439 $1.32 Million
Q1 2019

Apr 12, 2019

SELL
$75.32 - $86.15 $16,721 - $19,125
-222 Reduced 1.48%
14,729 $1.42 Million
Q4 2018

Jan 25, 2019

BUY
$73.66 - $82.02 $185,917 - $207,018
2,524 Added 20.31%
14,951 $1.28 Million
Q3 2018

Nov 05, 2018

SELL
$66.94 - $77.43 $18,073 - $20,906
-270 Reduced 2.13%
12,427 $1.07 Million
Q2 2018

Jul 25, 2018

BUY
$64.91 - $73.36 $44,787 - $50,618
690 Added 5.75%
12,697 $959,000
Q1 2018

May 02, 2018

BUY
$70.39 - $84.15 $845,172 - $1.01 Million
12,007 New
12,007 $971,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track D.B. Root & Company, LLC Portfolio

Follow D.B. Root & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D.B. Root & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on D.B. Root & Company, LLC with notifications on news.